This is a Notice of Intent to award a sole-source, firm-fixed-price purchase order to Bruker Scientific, LLC for a MALDI Biotyper Sirius CA System to support clinical microbiology identification. The award is justified because only Bruker's direct successor system maintains compatibility with existing consumables, workflows, and validated methodologies, avoiding substantial re-validation and operational disruption. The current system is nearing the end of its service life, with manufacturer support ending in March 2027. Interested parties may submit a capability statement demonstrating relevant experience and technical capability. Responses must be submitted electronically to the specified contracting officer.